Overexpression of Brefeldin A-inhibited Guanine Nucleotide-exchange Protein 3 in Patients with Extramammary Paget’s Disease

Clicks: 1
ID: 321820
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #165 of 169 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 169 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Overexpression of brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) has been reported in estrogen receptor α-positive breast cancer (BC) tissues, with high BIG3 expression strongly associated with poor prognosis in patients with BC. This study investigated the expression pattern of BIG3 in patients with extramammary Paget's disease (EMPD) and evaluated its clinical significance. Sixty-one tissue and 30 serum samples were collected from patients with EMPD. Immunohistochemistry showed that most EMPD tissues were positive for BIG3 (57/61, 93.4%), and strong BIG3 intensity correlated with the degree of invasiveness, lymph node/distant metastasis, and overall survival. Serum BIG3 levels in EMPD patients with invasive lesions were significantly higher than those in patients with in situ lesions and correlated with the serum concentration of cytokeratin 19 fragment. Therefore, BIG3 expression may serve as a prognostic marker in patients with EMPD.
Reference Key
openalex_W7169891891 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tomofumi Kiyotoh, Soichiro Sawamura, Tselmeg Mijiddorj Myangat, Shuichi Shimada, Toshihiro Kimura, Kayo Kashiwada‐Nakamura, Ikko Kajihara, Katsunari Makino, Shinichi Masuguchi, Satoshi Fukushima
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag315
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.